BRIEF published on 11/26/2025 at 00:51, 4 months 2 days ago CureVac annonce les résultats de son assemblée générale extraordinaire Assemblée Générale Extraordinaire BioNTech Approbation Des Actionnaires CureVac Fusion Légale
BRIEF published on 11/26/2025 at 00:51, 4 months 2 days ago CureVac Announces Results of Extraordinary General Meeting BioNTech Extraordinary General Meeting CureVac Shareholders Approval Legal Merger
PRESS RELEASE published on 11/26/2025 at 00:46, 4 months 2 days ago CureVac Announces Voting Results of Extraordinary General Meeting CureVac announces approval of BioNTech's exchange offer for outstanding shares at Extraordinary General Meeting with over 99.16% approval rate BioNTech MRNA Technology Exchange Offer CureVac EGM Voting Results
BRIEF published on 11/24/2025 at 13:15, 4 months 3 days ago CureVac publie ses résultats financiers du troisième trimestre et des neuf premiers mois de 2025 Performance Financière CureVac Technologie De L'ARNm Résultats Du Troisième Trimestre 2025 Fusion BioNTech
BRIEF published on 11/24/2025 at 13:15, 4 months 3 days ago CureVac Reports Q3 and Nine-Month Financial Results for 2025 Financial Performance MRNA Technology CureVac Q3 2025 Results BioNTech Merger
PRESS RELEASE published on 11/24/2025 at 13:10, 4 months 3 days ago CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates CureVac announces financial results for Q3 and first nine months of 2025, BioNTech transaction progresses, EMA clearance received for cancer therapy CVHNLC sqNSCLC Financial Results Cancer Therapy CureVac BioNTech Transaction EMA Clearance
BRIEF published on 08/15/2025 at 13:32, 7 months 12 days ago CureVac Reports Q2 and H1 2025 Financial Results; Announces Key Developments Financial Results MRNA Technology CureVac Patent Resolution BioNTech Acquisition
BRIEF published on 08/15/2025 at 13:32, 7 months 12 days ago CureVac publie ses résultats financiers du deuxième trimestre et du premier semestre 2025 et annonce des développements clés Résultats Financiers CureVac Technologie De L'ARNm Résolution De Brevet Acquisition De BioNTech
PRESS RELEASE published on 08/15/2025 at 13:27, 7 months 12 days ago CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates CureVac announces Q2 2025 financial results, business updates & agreement with BioNTech for transformative mRNA treatments. Strong cash position Financial Results BioNTech CureVac MRNA Q2 2025
BRIEF published on 08/08/2025 at 02:20, 7 months 19 days ago CureVac Settles Patent Dispute with Pfizer/BioNTech MRNA Technology CureVac Pfizer/BioNTech Patent Resolution Vaccine Royalties
Published on 03/28/2026 at 01:00, 23 minutes ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 28 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:45, 2 hours 38 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 2 hours 53 minutes ago Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property
Published on 03/27/2026 at 21:58, 3 hours 25 minutes ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 3 hours 25 minutes ago Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025
Published on 03/27/2026 at 20:08, 5 hours 15 minutes ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 5 hours 53 minutes ago Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe
Published on 03/27/2026 at 19:30, 5 hours 53 minutes ago FONDAZIONE MAIRE PRESENTED IN BERLIN THE "CLIMATE GOALS" STUDY IN THE FRAMEWORK OF MAIRE EUROPEAN STRATEGY LEVERAGING ON GERMANY
Published on 03/27/2026 at 19:06, 6 hours 17 minutes ago Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 18:52, 6 hours 31 minutes ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 6 hours 31 minutes ago Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025
Published on 03/27/2026 at 18:40, 6 hours 43 minutes ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
